We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
-20.55%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$761M
AUM Growth
+$324M
Cap. Flow
+$462M
Cap. Flow %
60.75%
Top 10 Hldgs %
9.83%
Holding
1,302
New
602
Increased
163
Reduced
60
Closed
477

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$15.9M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$9.6M
3
HCA icon
HCA Healthcare
HCA
+$8.15M
4
COP icon
ConocoPhillips
COP
+$8.08M
5
ILMN icon
Illumina
ILMN
+$7.69M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$7.5M
2
O icon
Realty Income
O
+$4.54M
3
ZBH icon
Zimmer Biomet
ZBH
+$4.2M
4
AAL icon
American Airlines Group
AAL
+$4.17M
5
DOW icon
Dow Inc
DOW
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 16.21%
2 Consumer Discretionary 13.41%
3 Financials 12.51%
4 Industrials 11.01%
5 Healthcare 10.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGNE icon
801
Neurogene
NGNE
$649M
$14K ﹤0.01%
+680
New +$16.6K
AVTX icon
802
Avalo Therapeutics
AVTX
$1B
$13K ﹤0.01%
+9
New +$12K
CRIS icon
803
Curis
CRIS
$9.82M
$13K ﹤0.01%
+33
New +$13.8K
DNTH icon
804
Dianthus Therapeutics
DNTH
$5.57B
$13K ﹤0.01%
+672
New +$16.6K
ELTX icon
805
Elicio Therapeutics
ELTX
$75.4M
$13K ﹤0.01%
+1,116
New +$17.8K
ASXC
806
DELISTED
Asensus Surgical, Inc.
ASXC
$13K ﹤0.01%
+31,620
New +$14.1K
MTEM
807
DELISTED
Molecular Templates, Inc.
MTEM
$13K ﹤0.01%
+915
New +$21.4K
KOPN icon
808
Kopin
KOPN
$599M
$12K ﹤0.01%
+10,891
New +$16.3K
LITS
809
Lite Strategy Inc
LITS
$32.5M
$11K ﹤0.01%
+936
New +$10.2K
NCMI icon
810
National CineMedia
NCMI
$370M
$11K ﹤0.01%
+1,204
New +$20.4K
SEEL
811
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$11K ﹤0.01%
+4
New +$10.4K
TRVN
812
DELISTED
Trevena, Inc.
TRVN
$11K ﹤0.01%
+43
New +$9.46K
IBIO icon
813
iBio
IBIO
$66.1M
$10K ﹤0.01%
+72
New +$10.8K
SMMT icon
814
Summit Therapeutics
SMMT
$10B
$10K ﹤0.01%
+10,355
New +$14.5K
SYRS
815
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$10K ﹤0.01%
+1,013
New +$9.48K
AKBA icon
816
Akebia Therapeutics
AKBA
$335M
$9K ﹤0.01%
+25,303
New +$10.6K
ARDX icon
817
Ardelyx
ARDX
$1.24B
$9K ﹤0.01%
+14,472
New +$10.7K
LTRPA
818
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$9K ﹤0.01%
+12,277
New +$15.8K
ATHX
819
DELISTED
Athersys, Inc. Common Stock
ATHX
$9K ﹤0.01%
+1,452
New +$16.1K
MBIO icon
820
Mustang Bio
MBIO
$4.44M
$7K ﹤0.01%
+16
New +$8.86K
RMO
821
DELISTED
Romeo Power, Inc.
RMO
$7K ﹤0.01%
+14,683
New +$13.8K
ATNX
822
DELISTED
Athenex, Inc. Common Stock
ATNX
$6K ﹤0.01%
+777
New +$8.68K
LOTZ
823
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$5K ﹤0.01%
+11,867
New +$8.78K
AMPE
824
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$5K ﹤0.01%
+92
New +$6.85K
QTNT
825
DELISTED
Quotient Limited Ordinary Shares
QTNT
$4K ﹤0.01%
+439
New +$9.37K

Similar funds

Y-Intercept (HK)'s Q2 2022 Portfolio in Review

As of Q2 2022, Y-Intercept (HK) held 1,302 positions worth $761M, up 74% from $437M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Y-Intercept (HK) deployed $462M of net new capital in Q2 2022, opening 602 new positions and adding to 163 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 30,610 shares worth $8.36M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was CenterPoint Energy, an estimated $1.92M trimmed.

  • Y-Intercept (HK)'s largest Q2 2022 buy was Berkshire Hathaway Class B: 30,610 shares worth $8.36M.
  • Y-Intercept (HK) added most to Apple in Q2 2022, an estimated $15.9M increase.
  • Y-Intercept (HK)'s biggest Q2 2022 reduction was CenterPoint Energy, cutting an estimated $1.92M.
  • Y-Intercept (HK) fully exited Linde in Q2 2022, selling an estimated $7.5M.
  • Y-Intercept (HK)'s ten largest holdings make up 9.8% of its $761M portfolio in Q2 2022.
  • Y-Intercept (HK) opened 602 new positions and closed 477 in Q2 2022.
  • Y-Intercept (HK)'s portfolio value rose 74% quarter-over-quarter to $761M.

Based on Y-Intercept (HK)'s 13F filing for Q2 2022, filed 8 Aug 2022.